India’s First Indigenous HPV Test Validated To Make Cervical Cancer Detection Affordable

New Delhi (Raghwendra Pratap Singh) : India has achieved an important milestone by successfully validating its first indigenous Human Papillomavirus (HPV) test for cervical cancer screening. The development is expected to make cervical cancer detection more affordable and accessible, especially for women living in rural and underserved areas. Cervical cancer is one of the most common cancers among women in India, and early detection plays a crucial role in reducing deaths caused by the disease.

However, HPV screening rates in India have been low because many existing HPV tests are expensive and require advanced laboratory facilities. The new indigenous test addresses these challenges by offering a reliable and cost-effective alternative that can be used more widely across the country. This reflects India’s growth in medical research and diagnostic innovation.

The validated test has been developed through a collaborative effort which involves Indian researchers, healthcare institutions, and international experts. Scientists from the All India Institute of Medical Sciences (AIIMS), Indian Council of Medical Research (ICMR) institutes, and the World Health Organization’s International Agency for Research on Cancer (IARC) participated in the validation process. The successful evaluation confirms that the test meets international quality standards and performs at a level comparable to globally accepted HPV screening tests.

Why Is HPV Screening Important :

Human Papillomavirus, commonly known as HPV, is the leading cause of cervical cancer. Certain high-risk HPV types can cause changes in cervical cells that may eventually develop into cancer if left untreated. Regular screening helps identify these infections and abnormal cell changes before cancer develops.